date:Apr 02, 2014
e for the beginning of the year. In effect, 2013 registered strong sales for Svetol 3 in the 1st half in response to extensive media coverage and Toll Manufacturing sales were very robust in the 1st quarter and will remain very sustained in 2014 as from the 2nd quarter. Furthermore, major new projects in progress will gradually generate revenue over the year.
Naturex, that completed a new acquisition at the end of 2013 by a majority stake in Chile Botanics, intends to pursue its strategy of tar